Lipid-Lowering Therapies Could Reduced Risk of Venous Thromboembolism: Study Jacinthlyn Sylvia5 July 2024 8:00 AM ISTA recent research published in the European Heart Journal unveiled promising evidence that lipid-lowering therapies (LLT) may significantly reduce the...
Evinacumab effective and well tolerated for LDL cholesterol lowering in refractory hypercholesterolemia patients: JAMA Medha Baranwal19 Sept 2023 11:30 AM ISTUSA: A recent study published in JAMA Cardiology has demonstrated the potential utility of evinacumab as an effective and generally well-tolerated...
Change in percent atheroma volume could be surrogate marker for adverse CV events: JAMA Medha Baranwal16 Sept 2023 11:45 AM ISTCanada: In a comprehensive meta-analysis published in JAMA Cardiology by Iulia Iatan and colleagues related to lipid-lowering therapy trials, a 1%...
Lipid-lowering drugs impart cardiovascular benefits across all ethnicities and regions: Study Dr. Kamal Kant Kohli28 Feb 2023 9:30 AM ISTAustralia: Regional and ethnic minority groups derive at least as much cardiovascular benefit as majority groups from lipid-lowering therapies,...
Evinacumab gets FDA nod for treatment of rare homozygous FH in children Medha Baranwal12 Feb 2021 7:30 PM ISTUSA: The U.S. Food and Drug Administration (FDA) has given its approval to Regeneron's evinacumab (Evkeeza) as an adjunct to other low-density...
Cholesterol drug combinations could cut complications risk in CV patients Hina Zahid29 Aug 2020 12:30 PM ISTNew findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk...
